INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 141 filers reported holding INTERSECT ENT INC in Q1 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,935,000 | +451.1% | 140,474 | +437.7% | 0.00% | – |
| Q4 2021 | $714,000 | -79.4% | 26,127 | -79.5% | 0.00% | -100.0% |
| Q3 2021 | $3,465,000 | -63.7% | 127,384 | -77.2% | 0.00% | -50.0% |
| Q2 2021 | $9,542,000 | -40.7% | 558,370 | -27.5% | 0.00% | -50.0% |
| Q1 2021 | $16,078,000 | -33.1% | 769,957 | -26.6% | 0.00% | -33.3% |
| Q4 2020 | $24,016,000 | +25.8% | 1,048,739 | -10.4% | 0.01% | +20.0% |
| Q3 2020 | $19,091,000 | +962.4% | 1,170,574 | +782.4% | 0.01% | +400.0% |
| Q2 2020 | $1,797,000 | +200.5% | 132,662 | +163.1% | 0.00% | – |
| Q1 2020 | $598,000 | -53.4% | 50,423 | -2.2% | 0.00% | – |
| Q4 2019 | $1,284,000 | -67.7% | 51,547 | -77.9% | 0.00% | -100.0% |
| Q3 2019 | $3,974,000 | -40.5% | 233,639 | -20.4% | 0.00% | -33.3% |
| Q2 2019 | $6,677,000 | +294.9% | 293,383 | +457.7% | 0.00% | – |
| Q1 2019 | $1,691,000 | -63.5% | 52,610 | -68.0% | 0.00% | -100.0% |
| Q4 2018 | $4,638,000 | -44.4% | 164,615 | -43.2% | 0.00% | -33.3% |
| Q3 2018 | $8,338,000 | +207.2% | 290,030 | +300.1% | 0.00% | +200.0% |
| Q2 2018 | $2,714,000 | +31.2% | 72,496 | +37.8% | 0.00% | 0.0% |
| Q1 2018 | $2,068,000 | -44.7% | 52,614 | -54.4% | 0.00% | -50.0% |
| Q4 2017 | $3,738,000 | +157.8% | 115,374 | +147.8% | 0.00% | +100.0% |
| Q3 2017 | $1,450,000 | -20.3% | 46,557 | -28.5% | 0.00% | -50.0% |
| Q2 2017 | $1,820,000 | +883.8% | 65,104 | +502.4% | 0.00% | – |
| Q1 2017 | $185,000 | -66.9% | 10,807 | -76.6% | 0.00% | -100.0% |
| Q4 2016 | $559,000 | -89.4% | 46,196 | -86.1% | 0.00% | -80.0% |
| Q3 2016 | $5,258,000 | +496.1% | 331,952 | +386.8% | 0.01% | +400.0% |
| Q2 2016 | $882,000 | +152.0% | 68,184 | +270.6% | 0.00% | – |
| Q1 2016 | $350,000 | -41.9% | 18,397 | -12.6% | 0.00% | -100.0% |
| Q2 2015 | $602,000 | +256.2% | 21,054 | +93.3% | 0.00% | – |
| Q3 2014 | $169,000 | – | 10,894 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |